We’re dedicated to creating a world where everyone has access to lifesaving cell therapies
Will you join us?
Our Products
The possibilities are limitless
A microfluidics-based platform for gene editing
Our products are designed with industry pioneers in mind. The CellFE platform features an easy-to-use benchtop device for research and process development of cell therapies.
Our Technology
A new class of cell therapy manufacturing with microfluidics
The revolutionary microfluidics-based cellular engineering technology maintains cell health, produces high yields, and supports rapid, complex genome editing. Our technology elegantly surpasses current industry standards, so cell therapy innovators can seamlessly scale from research to clinical to commercial.
WHo We Serve
Together, we will transform the lives of millions of people around the world
Despite the tremendous transformative potential of cell therapies, only a fraction of patients have access to these lifesaving therapies. This is a consequence of several challenges, including long vein-to-vein times, scalability challenges, and the high costs of manufacturing.
>90%
viability
with superior cell health and functionality
10+
kb payload
delivery with any cell type
1
million to billions of cells
scalability from discovery to commercial manufacturing
1-2
days
manufacturing process, including complex editing
0
required
viral vectors
Changing the world of cell therapy is a team effort
We’re privileged to work together with advanced cell therapy researchers and developers who are revolutionizing the future of medicine worldwide. Discover how our team enables our partners’ success.
About Us
We’re a passionate, diverse team dedicated to helping our partners advance cell therapies
At CellFE, we combine decades of experience across multiple disciplines — all with a single-minded focus to support cell therapy innovators in producing superior, effective treatments for patients worldwide.
Start the conversation
We partner with researchers and developers to streamline your cellular engineering workflows and achieve higher yields of safe, healthy cells. We want to hear from you.
